ZUG, Switzerland--(BUSINESS WIRE)--Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by EPAX Pharma UK Limited, the UK subsidiary of Trygg Pharma AS, based in Norway, for the provision of engineering, procurement and construction management (EPCm) services to convert parts of the former Lundbeck pharmaceutical plant at Seal Sands, Teesside, UK, to process fish oil to produce an omega-3 active pharmaceutical ingredient.
